NEMERA · 3 days ago
APU Shift Leader (APU 1 D)
Nemera is a leading global manufacturer of complex drug delivery systems for the pharmaceutical industry. The APU Shift Leader will oversee production employees, ensure compliance with company policies, and coordinate training and scheduling while maintaining high standards of safety and quality.
BiotechnologyHealth CareManufacturingMedical Device
Responsibilities
Support and maintain all policies of the company including but not limited to ISO Standards, Health and Safety Requirements, Continuous Improvement as well as standard work procedures
Monitor customer specification sheets and appropriate processing sheets
Ensure responses to corrective action requests are accurate, complete and timely
Supervise and maintain housekeeping, 5S standards and Autonomous Maintenance activities
Supervise and assist in mold set ups and start-ups
Coordinate production reports
Delegate responsibilities to technicians and other employees, when applicable
Organize meetings for all employees to facilitate communication and resolve issues
Coordinate all employee training
Maintain attendance records
Take necessary corrective or disciplinary actions with subordinates as necessary
Document all employee conflicts or problems and forward to the Production Manager or Human Resources
Daily scheduling of operators
Coordinate the issuing of tool repair request and maintenance work orders
Supervise all production employees
Other duties as assigned
Qualification
Required
High School Diploma or equivalent
3 years injection molding experience required
Ability to lift 50 lbs
Ability to stand, sit and walk up to 90% of shift
Ability to bend, stoop, reach, push, pull, grab, and climb as needed
Preferred
2 + years of leadership and or supervisory experience strongly preferred
Mechanical aptitude
Ability to work on Microsoft Office, Word, Excel
Basic SAP knowledge
Knowledge of inspection technicians
Company
NEMERA
Nemera is one of the world leaders in the design, development and manufacturing of high quality innovative drug delivery solutions.
Funding
Current Stage
Late StageTotal Funding
unknown2018-10-17Acquired
Recent News
Company data provided by crunchbase